A PHASE 1, OPEN-LABEL, FIXED SEQUENCE 2-PERIOD STUDY TO INVESTIGATE THE EFFECT OF MULTIPLE DOSES OF ITRACONAZOLE ON THE PHARMACOKINETICS OF A SINGLE DOSE OF PF-06700841 IN HEALTHY PARTICIPANTS
Latest Information Update: 31 Jan 2020
At a glance
- Drugs Brepocitinib (Primary) ; Itraconazole
- Indications Alopecia areata; Atopic dermatitis; Crohn's disease; Inflammatory bowel diseases; Plaque psoriasis; Psoriatic arthritis; Systemic lupus erythematosus; Ulcerative colitis; Vitiligo
- Focus Pharmacokinetics
- Sponsors Pfizer
Most Recent Events
- 28 Jan 2020 Status changed from recruiting to completed.
- 24 Oct 2019 Planned End Date changed from 19 Nov 2019 to 19 Dec 2019.
- 24 Oct 2019 Planned primary completion date changed from 19 Nov 2019 to 19 Dec 2019.